{"id":35336,"date":"2023-02-27T16:19:08","date_gmt":"2023-02-27T13:19:08","guid":{"rendered":"https:\/\/www.commercialcafe.com\/blog\/?p=35336"},"modified":"2025-03-25T16:09:03","modified_gmt":"2025-03-25T13:09:03","slug":"life-sciences-greater-boston","status":"publish","type":"post","link":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/","title":{"rendered":"Oxford Purchase $125 Million Life Sciences Asset in Greater Boston"},"content":{"rendered":"

Oxford Properties Group<\/strong> has completed the purchase of 92 Crowley Drive for $125 million. The 120,000-square-foot, state-of-the-art asset is in the life sciences submarket of Marlborough, Mass<\/a>., and is near completion. Biotech manufacturer Resilience<\/strong> (National Resilience) sold the facility to Oxford in a sale leaseback deal and will continue to occupy the property for up to 30 years.<\/p>\n

The property at 92 Crowley Drive will feature dedicated, multimodal manufacturing suites, as well as warehouse and office space. Notably, the high-tech facility is a perfect fit for technology-focused Resilience and will become its flagship location once operational. Resilience has expanded rapidly since its establishment in November 2020 operating multiple multimodal manufacturing facilities across North America. Earlier this month, Resilience signed a 10-year biomanufacturing partnership with an undisclosed \u201cleading pharmaceutical company.\u201d<\/p>\n

The latest transaction is the third sale and leaseback between Oxford and Resilience, further cementing their strategic partnership and shared plans for expansion. The deal allows Resilience to focus resources on science and development, while Oxford offers its investment and experience in managing life sciences infrastructure.<\/p>\n

In 2017, Oxford began investing in the life sciences industry, developing its portfolio across key North American and European markets. Today, its North American portfolio comprises 1.4 million square feet with an additional 1 million square feet in the pipeline.<\/p>\n

What\u2019s more, the purchase of 92 Crowley provides further momentum to Oxford\u2019s strategy to become the market leader in good manufacturing practice (GMP<\/strong>) facility ownership. In North America, Oxford\u2018s GMP platform and pipeline has expanded to 12 facilities across six markets, with the largest concentration \u2014 totaling 775,000 square feet \u2014 in the life sciences hub of greater Boston.<\/p>\n

Boston\u2019s Life Sciences Suburbanization<\/strong><\/p>\n

Boston maintains its dominance in the life sciences industry with world-class research institutions, available talent and funding. In fact, the region leads the industry with both the largest real estate market and largest labor force employed, which is further evidenced in the area\u2019s 13.2% growth of biopharma employment in 2021.<\/p>\n

And, with a life sciences real estate supply-demand imbalance, Boston continues to expand from its historical epicenter of Kendall Square to new and emerging clusters around the state. As a potential example of this trend, all five GMP facilities in the Boston region owned by Oxford are in the suburban spillovers of Farnborough, Medford, Bedford or Marlborough, Mass.<\/p>\n

Plus, the wider Boston life sciences market shows no sign of slowing down: The Massachusetts Biotechnology Council<\/strong> reported in 2022 that 1.7 million square feet of GMP space, as well as another 14.86 million square feet of lab space, was under construction.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Oxford Properties Group has completed the purchase of 92 Crowley Drive for $125 million. The 120,000-square-foot, state-of-the-art asset is in the life sciences submarket of Marlborough, Mass., and is near completion. Biotech manufacturer Resilience (National Resilience) sold the facility to Oxford in a sale leaseback deal and will continue to occupy the property for up…<\/p>\n","protected":false},"author":3163,"featured_media":35365,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[37,38,4014],"tags":[],"class_list":["post-35336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-commercial-real-estate-news","category-deals","category-featured","wpautop"],"acf":[],"yoast_head":"\nOxford Expand Life Sciences Portfolio with Purchase in Greater Boston<\/title>\n<meta name=\"description\" content=\"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oxford Purchase $125 Million Life Sciences Asset in Greater Boston\" \/>\n<meta property=\"og:description\" content=\"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/\" \/>\n<meta property=\"og:site_name\" content=\"CommercialCafe\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-27T13:19:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-25T13:09:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"469\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Matthew Preston\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Matthew Preston\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/\",\"url\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/\",\"name\":\"Oxford Expand Life Sciences Portfolio with Purchase in Greater Boston\",\"isPartOf\":{\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg\",\"datePublished\":\"2023-02-27T13:19:08+00:00\",\"dateModified\":\"2025-03-25T13:09:03+00:00\",\"author\":{\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/44a8a1fa2b4207afba1c2bb0ef1e2d80\"},\"description\":\"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage\",\"url\":\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg\",\"contentUrl\":\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg\",\"width\":1200,\"height\":469,\"caption\":\"Greater Boston life sciences\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.commercialcafe.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oxford Purchase $125 Million Life Sciences Asset in Greater Boston\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/#website\",\"url\":\"https:\/\/www.commercialcafe.com\/blog\/\",\"name\":\"CommercialCafe\",\"description\":\"Your Commercial Real Estate Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.commercialcafe.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/44a8a1fa2b4207afba1c2bb0ef1e2d80\",\"name\":\"Matthew Preston\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2026\/04\/Matthew-Preston.png?w=96\",\"contentUrl\":\"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2026\/04\/Matthew-Preston.png?w=96\",\"caption\":\"Matthew Preston\"},\"description\":\"Matthew has covered commercial real estate for CommercialCafe since 2022. He focuses on the office and industrial sectors, reporting on leasing, development, and investment across national markets and individual submarkets. His work draws on data and original research. He also writes about demographic shifts and urban innovation in U.S. cities. The New York Times, The Real Deal, Bisnow, The Business Journals, and Yahoo Finance have cited his reporting.\",\"jobTitle\":\"Content Writer, CRE News & Market Analysis\",\"url\":\"https:\/\/www.commercialcafe.com\/blog\/author\/matthew-preston\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Oxford Expand Life Sciences Portfolio with Purchase in Greater Boston","description":"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/","og_locale":"en_US","og_type":"article","og_title":"Oxford Purchase $125 Million Life Sciences Asset in Greater Boston","og_description":"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.","og_url":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/","og_site_name":"CommercialCafe","article_published_time":"2023-02-27T13:19:08+00:00","article_modified_time":"2025-03-25T13:09:03+00:00","og_image":[{"width":1200,"height":469,"url":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg","type":"image\/jpeg"}],"author":"Matthew Preston","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Matthew Preston","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/","url":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/","name":"Oxford Expand Life Sciences Portfolio with Purchase in Greater Boston","isPartOf":{"@id":"https:\/\/www.commercialcafe.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage"},"image":{"@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage"},"thumbnailUrl":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg","datePublished":"2023-02-27T13:19:08+00:00","dateModified":"2025-03-25T13:09:03+00:00","author":{"@id":"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/44a8a1fa2b4207afba1c2bb0ef1e2d80"},"description":"Oxford Properties Group purchase a $125 million life sciences asset in a sale leaseback deal increasing their portfolio footprint in Greater Boston.","breadcrumb":{"@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#primaryimage","url":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg","contentUrl":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg","width":1200,"height":469,"caption":"Greater Boston life sciences"},{"@type":"BreadcrumbList","@id":"https:\/\/www.commercialcafe.com\/blog\/life-sciences-greater-boston\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.commercialcafe.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Oxford Purchase $125 Million Life Sciences Asset in Greater Boston"}]},{"@type":"WebSite","@id":"https:\/\/www.commercialcafe.com\/blog\/#website","url":"https:\/\/www.commercialcafe.com\/blog\/","name":"CommercialCafe","description":"Your Commercial Real Estate Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.commercialcafe.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/44a8a1fa2b4207afba1c2bb0ef1e2d80","name":"Matthew Preston","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.commercialcafe.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2026\/04\/Matthew-Preston.png?w=96","contentUrl":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2026\/04\/Matthew-Preston.png?w=96","caption":"Matthew Preston"},"description":"Matthew has covered commercial real estate for CommercialCafe since 2022. He focuses on the office and industrial sectors, reporting on leasing, development, and investment across national markets and individual submarkets. His work draws on data and original research. He also writes about demographic shifts and urban innovation in U.S. cities. The New York Times, The Real Deal, Bisnow, The Business Journals, and Yahoo Finance have cited his reporting.","jobTitle":"Content Writer, CRE News & Market Analysis","url":"https:\/\/www.commercialcafe.com\/blog\/author\/matthew-preston\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.commercialcafe.com\/blog\/wp-content\/uploads\/sites\/10\/2023\/02\/Worcester-Boston-office-and-life-science-space.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/posts\/35336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/users\/3163"}],"replies":[{"embeddable":true,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/comments?post=35336"}],"version-history":[{"count":5,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/posts\/35336\/revisions"}],"predecessor-version":[{"id":35348,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/posts\/35336\/revisions\/35348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/media\/35365"}],"wp:attachment":[{"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/media?parent=35336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/categories?post=35336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.commercialcafe.com\/blog\/wp-json\/wp\/v2\/tags?post=35336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}